Individuals & Families
Small Businesses
Nonprofits
Employers
Employee Benefits Brokers
PEOs
Credit Unions
Membership Groups
Legal Information
Sign In
/
U.S. Code of Federal Regula...
/
Title 21-Food and Drugs
/
CHAPTER I—FOOD AND DRUG ADM...
/
PART 212—CURRENT GOOD MANUFACTURING PRACTICE FO...
PART 212—CURRENT GOOD MANUFACTURING PRACTICE FOR POSITRON EMISSION TOMOGRAPHY DRUGS
§ 212.1 - What are the meanings of the technical terms used in these regulations?
§ 212.2 - What is current good manufacturing practice for PET drugs?
§ 212.5 - To what drugs do the regulations in this part apply?
§ 212.10 - What personnel and resources must I have?
§ 212.20 - What activities must I perform to ensure drug quality?
§ 212.30 - What requirements must my facilities and equipment meet?
§ 212.40 - How must I control the components I use to produce PET drugs and the containers and closures I package them in?
§ 212.50 - What production and process controls must I have?
§ 212.60 - What requirements apply to the laboratories where I test components, in-process materials, and finished PET drug products?
§ 212.61 - What must I do to ensure the stability of my PET drug products through expiry?
§ 212.70 - What controls and acceptance criteria must I have for my finished PET drug products?
§ 212.71 - What actions must I take if a batch of PET drug product does not conform to specifications?
§ 212.80 - What are the requirements associated with labeling and packaging PET drug products?
§ 212.90 - What actions must I take to control the distribution of PET drug products?
§ 212.100 - What do I do if I receive a complaint about a PET drug product produced at my facility?
§ 212.110 - How must I maintain records of my production of PET drugs?